Reviva Pharmaceuticals I... (RVPHW)
0.22
-0.01 (-4.35%)
At close: Jan 15, 2025, 3:33 PM
0.20
-6.54%
After-hours Jan 15, 2025, 03:34 PM EST
undefined% (undefined)
| Bid | 0.17 |
| Market Cap | 73.19M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 0 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.27 |
| Volume | 17,561 |
| Avg. Volume (20D) | 0 |
| Open | 0.22 |
| Previous Close | 0.23 |
| Day's Range | 0.19 - 0.22 |
| 52-Week Range | 0.19 - 0.22 |
| Beta | undefined |
About RVPHW
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as ...
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 15
Stock Exchange NASDAQ
Ticker Symbol RVPHW
Website https://www.revivapharma.com